+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 1Year - 18Years
All Genders
ID06684639

Study of Autologous GD2-CAR T Cell Therapy for Children with Relapsed or Refractory Neuroblastoma

Led by The General Hospital of Western Theater Command · Updated on 2024-12-20

30

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Neuroblastoma is a cancer of the sympathetic nervous system, and patients with high-risk, relapsed, or refractory neuroblastoma face poor outcomes. This trial investigates the safety and effectiveness of GD2-CAR T cell therapy, which targets the GD2 antigen found on nearly all neuroblastoma tumors. The study is an early-phase clinical trial aimed at exploring new treatment options for this condition where current therapies have limitations. Participants will receive escalating doses of GD2-CAR T cells, starting from a low dose and increasing if no significant side effects occur, up to the maximum tolerated dose. The treatment involves intravenous infusion of these engineered cells. Researchers will monitor adverse events, neurological and hematological effects, infections, and secondary tumors from the time of infusion up to 24 months. The study will also evaluate response rates, recurrence, progression-free survival, overall survival, and the persistence of the CAR T cells in the body. Throughout the study, participants will undergo assessments to measure treatment response at 3 months and long-term outcomes up to 5 years. Safety monitoring includes collecting data on adverse events for 24 months after infusion. Evaluations will include physical exams, laboratory tests, heart and lung function assessments, and pregnancy tests for women. Participants are expected to be followed regularly to monitor their health and the therapys impact, with total study duration extending up to several years.

CONDITIONS

Brief Title

A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma

Research Team

J

JunXia Wang, Ph.D

H

Hai Yi, Ph.D

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here